文献速递血脂与心血管预防

高甘油三酯血症管理中辅助降脂治疗的未满足需求

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management.
PubMed 文献 · J Am Coll Cardiol · 2018-06-20

本文综述了高甘油三酯血症患者在优化他汀治疗后仍存在的残余心血管风险,指出贝特类、烟酸及多数CETP抑制剂未能显示额外事件减少,而ω-3脂肪酸虽可降低TG但缺乏临床结局数据。多项优化剂量ω-3脂肪酸的随机对照试验即将完成。

要点

  • 高TG和非HDL-C是残余ASCVD风险的重要介导因素,获遗传学支持。
  • 贝特类、烟酸及多数CETP抑制剂在他汀优化LDL-C后未显示增量事件减少。
  • ω-3脂肪酸可降低TG并可能有多效性,但临床结局数据尚缺乏。

核心结论

  • 高甘油三酯血症患者在他汀优化LDL-C治疗后仍存在显著残余风险,辅助降脂治疗需求未满足。

研究设计与样本

  • 综述性文章,总结既往降TG/HDL-C试验及正在进行的ω-3脂肪酸随机对照试验。

主要发现

  • 贝特类、烟酸及多数CETP抑制剂在他汀优化LDL-C后未显示增量事件减少。
  • ω-3脂肪酸可有效降低TG水平,并可能减少斑块不稳定性和促炎介质。
  • ω-3脂肪酸的临床结局数据目前缺乏,多项优化剂量随机对照试验接近完成。

临床怎么用

  • 对高TG患者应关注残余ASCVD风险,但现有辅助降脂药物缺乏结局证据。
  • ω-3脂肪酸可考虑用于降低TG,但需等待正在进行的结局试验结果。

局限性

  • ω-3脂肪酸临床结局数据缺乏。
  • 既往贝特类、烟酸及CETP抑制剂试验未显示增量事件减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the important role of high-intensity statins in reducing atherosclerotic cardiovascular disease events in secondary and primary prevention, substantial residual risk persists, particularly among high-risk patients with type 2 diabetes mellitus, metabolic syndrome, and obesity. Considerable attention is currently directed to the role that elevated triglycerides (TGs) and non-high-density lipoprotein cholesterol levels play as important mediators of residual atherosclerotic cardiovascular disease risk, which is further strongly supported by genetic linkage studies. Previous trials with fibrates, niacin, and most cholesterol ester transfer protein inhibitors that targeted high-density lipoprotein cholesterol raising, and/or TG lowering, have failed to show conclusive evidence of incremental event reduction after low-density lipoprotein cholesterol levels were "optimally controlled" with statins. Although omega-3 fatty acids are efficacious in lowering TG levels and may have pleiotropic effects such as reducing plaque instability and proinflammatory mediators of atherogenesis, clinical outcomes data are currently lacking. Several ongoing randomized controlled trials of TG-lowering strategies with an optimal dosage of omega-3 fatty acids are nearing completion.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ganda OP, Bhatt DL, Mason RP, et al. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management. J Am Coll Cardiol. 2018. PMID: 29935936. doi:10.1016/j.jacc.2018.04.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。